Related Experiment Video
Updated: Mar 26, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
The effect of oxygen saturation targeting on retinal blood vessel growth using retinal image data from the BOOST-II
R B R Moreton1, B W Fleck2, A R Fielder3
1Academic Foundation Programme Trainee, Edinburgh, UK.
Insights
Higher oxygen saturation (91-95%) in preterm infants showed a trend toward reduced retinal blood vessel growth compared to lower targets (85-89%). This finding suggests careful oxygen management is crucial for preventing retinopathy of prematurity complications.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatric Medicine
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Developing retinal blood vessels in preterm infants are susceptible to abnormal growth patterns.
- Oxygen saturation (SpO2) levels are a critical factor in neonatal care and ROP development.
Purpose of the Study:
- To investigate the impact of higher (91-95%) versus lower (85-89%) oxygen saturation targeting on retinal blood vessel growth in preterm infants.
- To compare temporal and nasal retinal blood vessel extension in relation to different SpO2 targets.
Main Methods:
- Utilized RetCam images from the BOOST-II UK trial for analysis.
- Measured distances between the optic disc center and ROP ridge in temporal and nasal retina.
- Compared retinal blood vessel growth in infants randomized to higher vs. lower SpO2 target groups.
Main Results:
- Temporal blood vessels naturally extended further than nasal vessels (P<0.0001).
- A trend towards reduced temporal retinal blood vessel growth was observed in the higher SpO2 target group (P=0.055).
- Nasal retinal blood vessel growth showed no significant difference between the SpO2 target groups (P=0.38).
Conclusions:
- Higher oxygen saturation targeting (91-95%) may be associated with decreased retinal blood vessel growth in preterm infants.
- These findings suggest a potential link between oxygen management strategies and ROP progression.
- Further research is warranted to confirm these trends and optimize SpO2 targets for ROP prevention.
Purpose:
Retinopathy of prematurity (ROP) is a disorder of developing retinal blood vessels in preterm infants. The purpose of this nested study was to investigate the effects of higher (91-95%) and lower (85-89%) oxygen saturation (SpO2) targeting on retinal blood vessel growth in preterm infants.
Methods:
Retinal blood vessel growth in the higher (91-95%) and lower (85-89%) oxygen saturation (SpO2) targeting groups was compared. Suitable RetCam (Clarity, Pleasanton, CA, USA) images collected in the BOOST-II UK trial were used. The distances between the centre of the optic disc and the ROP ridge in the temporal and nasal retina were measured in pixel units.
Results:
Images from 38 infants were studied, 20 from the higher SpO2 target group and 18 from the lower SpO2 target group. On average, temporal blood vessels extended further from the optic disc than nasal blood vessels, mean (standard deviation (SD)) 463.39 (55.05) pixels compared with 360.13 (44.47) pixels, respectively, P<0.0001. Temporal blood vessels extended less far from the optic disc in the higher SpO2 target group than in the lower SpO2 target group: mean (SD) 449.83 (56.16) pixels compared with 480.02 (49.94), respectively, P=0.055. Nasal retinal blood vessel measurements were broadly similar in the higher and lower SpO2 target groups; mean (SD) 353.96 (41.95) compared with 370.00 (48.82) pixels, respectively, P=0.38.
Conclusions:
Relatively high oxygen saturation targeting (91-95%) was associated with a trend (P=0.055) towards reduced retinal blood vessel growth in this study of preterm infants.
Related Concept Videos
Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

